CA
PODD icon

Cullinan Associates’s Insulet PODD Stock Holding History

Cullinan Associates’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Hold
2,500
– – 0.03% 176
2026
Q1 		$525K Buy
+2,500
New +$628K 0.04% 154

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cullinan Associates's PODD Position: Q2 2026 in Review

Cullinan Associates held its Insulet (PODD) position steady in Q2 2026 at 2,500 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #176.

Cullinan Associates first reported a position in PODD in Q1 2026 and has held it in 2 quarters since. The position peaked at $525K in Q1 2026. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Cullinan Associates held 2,500 shares of Insulet worth $381K as of Q2 2026.
  • Cullinan Associates left its Insulet share count unchanged in Q2 2026.
  • Insulet made up 0.03% of Cullinan Associates's portfolio in Q2 2026, its #176 holding.
  • Cullinan Associates first reported a position in Insulet in Q1 2026 and has held it in 2 quarters since.
  • Cullinan Associates's Insulet position peaked at $525K in Q1 2026.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.